Gene · 5885
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Darling: A Web Application for Detecting Disease-Related Biomedical Entity Associations with Literature Mining. | Biomolecules | 2022 | 35454109 | PubTator, text mining | PubMed |
| Active endogenous retroviral elements in human pluripotent stem cells play a role in regulating host gene expression. | Nucleic Acids Res | 2022 | 35451484 | PubTator, text mining | PubMed |
| Current Status of Epitranscriptomic Marks Affecting lncRNA Structures and Functions. | Noncoding RNA | 2022 | 35447886 | PubTator, text mining | PubMed |
| Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with RUNX1-RUNX1T1 or CBFB-MYH11 Fusions | Turk J Haematol | 2022 | 35445594 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Analysis of sub-kilobase chromatin topology reveals nano-scale regulatory interactions with variable dependence on cohesin and CTCF. | Nat Commun | 2022 | 35440598 | PubTator, text mining | PubMed |
| ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation. | Nat Commun | 2022 | 35440136 | PubTator, text mining | PubMed |
| Connecting high-resolution 3D chromatin organization with epigenomics. | Nat Commun | 2022 | 35440119 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| Recurrent transcriptional responses in AML and MDS patients treated with decitabine. | Exp Hematol | 2022 | 35429619 | PubTator, text mining | PubMed |
| Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. | J Hematol Oncol | 2022 | 35414025 | PubTator, text mining | PubMed |
| OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer. | Sci Rep | 2022 | 35413990 | PubTator, text mining | PubMed |
| A comparison of topologically associating domain callers over mammals at high resolution. | BMC Bioinformatics | 2022 | 35413815 | PubTator, text mining | PubMed |
| Interaction between cigarette smoking and genetic polymorphisms on the associations with age of natural menopause and reproductive lifespan: the Singapore Chinese Health Study. | Hum Reprod | 2022 | 35413122 | PubTator, text mining | PubMed |
| BRD2 compartmentalizes the accessible genome. | Nat Genet | 2022 | 35410381 | PubTator, text mining | PubMed |
| The Interplay of Cohesin and RNA Processing Factors: The Impact of Their Alterations on Genome Stability. | Int J Mol Sci | 2022 | 35409298 | PubTator, text mining | PubMed |
| Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development. | Int J Mol Sci | 2022 | 35408813 | PubTator, text mining | PubMed |
| A Comparison of the Genotoxic Effects of Gold Nanoparticles Functionalized with Seven Different Ligands in Cultured Human Hepatocellular Carcinoma Cells. | Nanomaterials (Basel) | 2022 | 35407243 | PubTator, text mining | PubMed |
| Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review. | Front Oncol | 2022 | 35402256 | PubTator, text mining | PubMed |
| ProbC: joint modeling of epigenome and transcriptome effects in 3D genome. | BMC Genomics | 2022 | 35397520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5885/papers?page=49